A multi-centre proof of concept study to assess efficacy and safety of endoscopic hemostasis with combined activated Factors IIa, VIIa, IXa and Xa (Seraseal/Fastact ®) in patients with acute gastrointestinal bleeding
Keyword(s):
Keyword(s):
2017 ◽
Vol 66
(12)
◽
pp. 1823-1830
◽
2015 ◽
Vol 9
(suppl 1)
◽
pp. S39-S39
◽